Recently, there was a clinical trial with anti-viral drug Remidasevir. Anti-viral drugs in the treatment of coronavirus 68% of patients with remidivirus are healthy. Of the 53 patients, 36 or 68 percent were healed. This was stated in a report in the New England Journal of Medicine. The report also noted that remodeciV is a broad-spectrum anti-viral drug used in the treatment of MERS, SARS and Ebola.
